Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04567225 · ClinicalTrials.gov registry record · Phase 4
Early Basal Insulin Administration in Adult Diabetic Ketoacidosis Management
A Phase 4 study, sponsored by The Cleveland Clinic.
- Terminated
- Registry status
- Phase 4
- Development phase
- 39
- Enrollment target
NCT04567225: Clinical Trial Phase 4 study, sponsored by The Cleveland Clinic.
NCT04567225 is a Phase 4 study that was terminated before completion, run by The Cleveland Clinic. The registered enrollment target is 39 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (92% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04567225, a Phase 4 study, was terminated before completion, sponsored by The Cleveland Clinic.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 39 participants
- Enrollment target
Study Summary
Early Basal Insulin Administration in Adult Diabetic Ketoacidosis Management
Primary Outcome
Measured in hours from starting insulin infusion till anion gap ≤ 12 milliequivalent/Liter (mEq/L)
Interventions
- OTHER IV insulin infusion
- DRUG Early Glargine
- DRUG Late Glargine
- OTHER IV fluid and electrolytes replacement
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 39 participants |
| Start Date | 2020-10-01 |
| Est. Completion | 2021-08-27 |
| Phase | Phase 4 |
Why NCT04567225 stopped before completion
NCT04567225 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 39 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (92% lower).
The record links to 0 conditions, and to 4 interventions - of which IV insulin infusion is the first listed.
NCT04567225 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04567225 about?
NCT04567225 is a clinical study titled "Early Basal Insulin Administration in Adult Diabetic Ketoacidosis Management". Early Basal Insulin Administration in Adult Diabetic Ketoacidosis Management
What is the current status of trial NCT04567225?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 39 participants. The study started on 2020-10-01. Estimated completion is 2021-08-27.
What interventions are being tested in trial NCT04567225?
The interventions under investigation include: IV insulin infusion (OTHER), Early Glargine (DRUG), Late Glargine (DRUG), IV fluid and electrolytes replacement (OTHER).
Who is sponsoring clinical trial NCT04567225?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04567225's enrollment target sits among peer trials
39 1468th of 2000 higher than 525 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03465592 · 39 participants · Phase 1
Trial of Nivolumab Following Partially Human Leukocyte Antigen (HLA) Mismatched BMT in Children & Adults With Sarcoma
- NCT03961776 · 39 participants
Monitoring Treatment Response With On-board DWI During Neo-adjuvant Chemo-radiation for Rectal Cancer Using Magnetic Resonance-guided-radiotherapy Systems
- NCT04050280 · 39 participants · Phase 2
CLAG-GO for Patients With Persistent, Relapsed or Refractory AML
- NCT04190862 · 39 participants · Phase 1
E-CEL UVEC as an Adjunct Cell Therapy for Treatment of Anal Fistulas
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI